We are excited to share the new MASCC/ISOO Clinical Practice Statements, created by our Oral Care Study Group. These guidance documents are designed to provide clinicians with concise, practical information on managing oral complications in cancer patients, based on the expert consensus of an international panel.
The Clinical Practice Statements cover the following topics:
- Clinical assessment of salivary gland hypofunction and xerostomia in cancer patients
- Current understanding on controversies in basic oral care in hemato-oncology and hematopoietic cell transplantation
- Management of oral complications of targeted therapy
- Management of salivary gland hypofunction and xerostomia in cancer patients
- Adjuvant bone-modifying agents in primary breast cancer patients – prevention of medication-related osteonecrosis of the jaw
- Management of oral manifestations of chronic graft-versus-host-disease
- The risk of secondary oral cancer following hematopoietic cell transplantation
